Curriculum Vitae

Tiffany Chow
MD, MSc

A. Date Curriculum Vitae is Prepared: 2011 August 10
Only includes Activities from January 2003 to August 2011
B. Biographical Information
1. EDUCATION
Degrees
1988 Sep - 1992 May	MD, Alternative Curriculum, Rush Medical College
1987 Jul - 1988 Jun	MSc, Marine Biology, Stanford University, Pacific Grove, California, United States
1987	Bachelor of Arts and Sciences, German Studies and Biological Sciences, Stanford University
Postgraduate, Research and Specialty Training
2006 Mar - 2008 Feb	Scholar, selected from Geriatric Psychiatry and Neurology Clinician-Scientists. Scholarship includes travel to annual meeting for grantsmanship workshop and continuing mentorship. Advanced Research Institute, National Institute of Mental Health, United States, Supervisor(s): Drs. Gwenn Smith and Bruce Pollock
2001 Jun	Visiting Fellow in Functional MRI, Nuclear Magnetic Resonance Division, Functional Imaging Analysis, Massachusetts General Hospital, Massachusetts, United States
1996 Jul - 1999 Jun	VA Geriatric Neurology Fellow in the Dementia and Behavioral Neuroscience Fellowship Program, Dementia and Behavioural Neurosciences, School of Medicine, University of California, Los Angeles, California, United States, Supervisor(s): Jeffrey L. Cummings
1993 - 1996	Neurology Residency, Neurology, School of Medicine, University of California, San Diego and La Jolla VA Medical Center, San Diego, California, United States, Supervisor(s): Mark Kritschevsky, MD
Qualifications, Certifications and Licenses
2003	Medical License, California, United States, G078493
2000	Certified, American Board of Neurology and Psychiatry, United States
1992	Academic License, College of Physicians and Surgeons of Ontario, Canada, 78892
2. EMPLOYMENT
Current Appointments
2010 Dec 6 - present	Senior Scientist, Rotman Research Institute, Behavioural Neurology, Dept of Medicine, Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada
2006 May 3 - present	Assistant Professor, Division of Geriatric Psychiatry, Faculty of Medicine, University of Toronto, Ontario, Canada
2003 Mar 1 - present	Assistant Professor, Division of Neurology, Dept of Medicine, University of Toronto, Ontario, Canada
2011 Jul 13 - 2016 Jun 30	Associate Member, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Previous Appointments
CLINICAL
2001 Jul - 2003 Feb	Director, Clinical Core of state-funded University of Southern California Alzheimer’s Disease Center of California, Faculty of Medicine, USC, Los Angeles, California, United States
2001 Jan - 2003 Feb	Co- Director, Clinical Core of NIA-funded Alzheimer’s Disease Research Center, Faculty of Medicine, USC, Los Angeles, California, United States
2000 Oct - 2003 Feb	Director, Frontotemporal Dementia Clinic, University of Southern California, California, United States
2000 Oct - 2003 Feb	Director, Neurology, Faculty of Medicine, Translational Core of Rancho Los Amigos/USC Alzheimer’s Disease Center, Los Angeles, California, United States
1998 Jul - 2000 Oct	Director, Neurology, University of California, Los Angeles, Frontotemporal Dementia Clinic, Los Angeles, California, United States
CONSULTING
2001 Jan - 2003 Feb	Consultant, Neurology, Faculty of Medicine, Rancho Los Amigos National Rehabilitation Center, Los Angeles, California, United States
HOSPITAL
2003 Mar 1 - 2010 Dec 6	Clinician-Scientist, Rotman Research Institute, Behavioural Neurology, Dept of Medicine, Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada
2000 Oct - 2001 Jan	Physician Specialist (Neurology), Adult Brain Injury Rehabilitation Unit, Adult Brain Injury, Neurology, Faculty of Medicine, Rancho Los Amigos National Rehabilitation Center, California, United States
UNIVERSITY - RANK
2000 Oct - 2003 Feb	Assistant Professor of Neurology, Neurology, Faculty of Medicine, University of Southern California, California, United States
2000 Jan - 2000 Sep	Assistant Clinical Professor, Step II, Neurology, Faculty of Medicine, University of California, Los Angeles, California, United States
1999 Jul 1 - 1999 Dec	Assistant Professor of Neurology, Neurology, Faculty of Medicine, University of California, Los Angeles, Los Angeles, California, United States
3. HONOURS AND CAREER AWARDS
Distinctions and Research Awards
NATIONAL
Received

2005 - 2007	NIH Loan Repayment Program, NIH. (Research Award)
Competition for Medical School Loan Repayment by NIH. Only clinicians dedicating careers to >=75% research are eligible. Total Amount: 53,549
2003 - 2005	Renewal of Award: NIH Loan Repayment Program, NIH. (Research Award)
Competition for Medical School Loan Repayment by NIH. Only clinicians dedicating careers to >=75% research are eligible, rare to be funded for two 2-year terms. Total Amount: 42,553 USD

LOCAL
Received

2009 Jul - present	1st Scientist supported by Women of Baycrest, Women of Baycrest, Ontario, Canada. (Distinction, Specialty: Clinician-Scientist)
Total Amount: 100,000 CAD
2007	Cole Family Travel Award, Baycrest Centre for Geriatric Care. (Travel Award)
Baycrest Frontotemporal Dementia Team to visit UCSF.

4. PROFESSIONAL AFFILIATIONS AND ACTIVITIES
Administrative Activities
INTERNATIONAL
Association for Frontotemporal Dementias	
2009 - present	Chair, Education Committee
2004 - present	Member, Medical Advisory Council
	
American Academy of Neurology, Geriatric Neurology Section	
2010 - 2011 Apr 15	Chair, Education Workgroup [served as Chair 2010-2011], United States.
	
University of California, San Francisco	
2007 - 2009	Member, External Advisory Panel, Alzheimer’s Disease Research Center (NIA), San Francisco, California, United States.
	
American Neuropsychiatric Association	
2006 - 2008	Chair, Scientific Program Committee, United States.
	
Baycrest Centre for Geriatric Care	
2008	Co-Chair, Rotman Research Institute Annual Conference on Imaging and Dementia, Toronto, Ontario, Canada.
2004 - 2005	Member, Planning Committee, Rotman Research Institute Annual Conference, Toronto, Ontario, Canada.
	
NIA	
2006	Invited Member, Initiatives in Behavioral Management in Dementia Planning Group Meeting, Washington D.C. United States.
2005	Member, Special Emphasis Panel for RFA-AG-05-006 “Collaborative Studies on Alzheimer and related disorders,”  Study Section, Bethesda, Maryland, United States.
	
NATIONAL
Alzheimer Society of Canada	
2008 Dec - present	Medical Advisor, Research Ambassadors, Toronto, Ontario, Canada.
	
Canadian Conference on Dementia	
2008 - present	Chair, Planning Committee, Toronto, Ontario, Canada.
	
Other Organizations	
2006	Invited Member, 3rd Canadian Consensus Conference on Diagnosis and Treatment of Dementia, Canada.
	
LOCAL
Baycrest	
2010 Oct - present	Research Participation Policy Implementation Working Group, Ontario, Canada.
	
Baycrest Centre for Geriatric Care	
2010 Jul 1 - present	Training Coordinator, Faculty of Medicine, Dept of Medicine, Neurology, Multilevel Education, Toronto, Ontario, Canada.
Coordinating U of T and extramural medical student and resident rotations through Baycrest Behavioural Neurology, coordinating the Beh Neurol Fellowship.
2009 - present	Member, Medical Education Committee, Faculty of Medicine, Dept of Medicine, No Division, Graduate Education, Toronto, Ontario, Canada.
2005 - present	Member, Behavioural Neurology Funds Allocation Committee
2005 - present	Member, Subjects Committee, Rotman Research Institute
	
University of Toronto	
2010 Jul 1 - present	Member, Medical Education Committee (AKA Residency Program), Faculty of Medicine, Dept of Medicine, Neurology, Graduate Education, Toronto, Ontario, Canada.
2009 - present	Member, Task Force, Behavioural Neurology Section City-Wide Registry, Faculty of Medicine, Dept of Medicine, Neurology, Toronto, Ontario, Canada.
2009 - present	Member, Plannning Committee, Gender Issues In Medicine, Faculty of Medicine, Dept of Medicine, Toronto, Ontario, Canada.
2008 - present	Member, Planning Committee, City-Wide Behavioural Neurology Rounds, Faculty of Medicine, Dept of Medicine, Neurology, Toronto, Ontario, Canada.
	
Rotman Research Institute, Baycrest Centre for Geriatric Care	
2009 - present	Member, KLARU and Rotman Combined Conference Committee, Toronto, Ontario, Canada.
	
Dancing with Parkinsons	
2008 - present	Medical Advisor, Toronto, Ontario, Canada.
	
Alzheimer Society of Toronto	
2006 - present	Member, Board of Directors, Toronto, Ontario, Canada.
	
Alzheimer’s Association of Los Angeles	
1998 - 2003	Board Member, Los Angeles, California, United States.
	
Peer Review Activities
GRANT REVIEWS
External Grant Reviewer	
2010 Jun 15	CIHR Institute on Aging, Number of Reviews: 1
2009	Alzheimer’s Association, Number of Reviews: 2
Reviewer	
2011 Jan 11 - 2011 Jan 13	CIHR Institute on Aging, Catalyst Grant: Pilot Projects in Aging, Number of Reviews: 11

MANUSCRIPT REVIEWS
Ad Hoc Reviewer	
2011 May	Brain, Number of Reviews: 1
2011 Feb	Neurocase, Number of Reviews: 1
2010 Jul	Human Brain Mapping, Number of Reviews: 2
2009 Jun	Archives of Neurology, Number of Reviews: 3

ALZHEIMER DISEASE RESEARCH CENTER EXTERNAL ADVISORY BOARD
External Reviewer	
2007 Feb 8 - present	UC San Francisco NIA-funded ADRC

OTHER
External Grant Reviewer	
2007	CIHR, Behavioural Sciences B Section
Ad Hoc Reviewer	
2004	Heart and Stroke Research Foundation of Canada, Grants-in Aid
Ad Hoc Reviewer, External Reviewer	
2007	CIHR, Collaborative Study in Dementia

C. Academic History
1. RESEARCH STATEMENTS
2010 Mar - present	Education for Young Caregivers for Frontotemporal Dementia.
In partnership with the Canadian Dementia Knowledge Transfer Network and Young Carers Intitiative.

2008 - present	RELATION OF BETA AMYLOID TO BEHAVIOURAL AND PSYCHIATRIC DISTURBANCES IN DEMENTIA.
Principal Investigator.

2007 Apr - present	The language impairment in progressive aphasia: a longitudinal neuropsychological and imaging study.
Co-Investigator, Elizabeth Rochon (PI).

2005 - present	Alexithymia in Frontotemporal Dementia.
Co-Investigator, Cheryl Grady, PhD (PI).

2009 - 2010	RELATION OF CHOLINERGIC RECEPTOR CHANGES TO DEVELOPMENT OF ALZHEIMER’S DISEASE.
Principal Investigator.

2006 Dec - 2011	Open Label Pilot Study of the Effects of Acute Memantine Administration on FDG-PET in Frontotemporal Dementia.
Principal Investigator.

2006 - 2008	Theory of Mind in Alzheimer’s Disease and Frontotemporal Dementia.
Co-Investigator, Morris Freedman, MD, FRCPC (PI).

2003 Mar - 2009	Serotonergic function and behavioral and psychological symptoms of frontotemporal dementia.
Co-Investigator, Nathan Herrmann (PI).

2003 - 2012	Frontal Aging Study.
Co-Investigator, Don Stuss, PhD (PI).

2003 - 2008 Jun	Serotonin receptor radioligands.
Principal Investigator.

2002 - 2003	Language Processing in Semantic Dementia and Functional MRI.
Principal Investigator.

2001 - 2003	Frontotemporal Dementia Consortium: Multi-Center Alzheimer’s Research Center of California, Rancho Los Amigos.
Site Investigator.

2001 - 2003	Depression in Alzheimer’s Disease: Multi-Center Alzheimer’s Research Centre of California Study, Rancho Los Amigos.
Site Investigator.

2. RESEARCH AWARDS
Grants, Contracts and Clinical Trials
PEER-REVIEWED GRANTS
Funded

2011 Aug - 2013 Jul	Principal Investigator. Relation of Beta-Amyloid Deposition to Temporal Lobe-Focused Dementias. NIA, R03. 98,366 USD. [Grants].

2011 Apr - 2012 Mar	Principal Investigator. When Dementia Is in the House. AHSC AFP. AFP Innovation Fund 2010-2011. Collaborators: Rockwood, Kenneth. 10,150 CAD. [Grants]
Funding to develop educational materials for children living with someone with Frontotemporal Dementia.

2011 Apr - 2012 Mar	Principal Investigator. When Dementia Is in the House. Canadian Dementia Knowledge Transfer Network. Collaborators: Rockwood, Kenneth, Young Carers Initiative. 20,000 CAD. [Grants]
Funding to develop educational materials for children living with someone with Frontotemporal Dementia.

2007 Apr - 2012 Mar	Co-Investigator. The Language Impairment in PPA: A Longitudinal Neuropsychological and Imaging Study. CIHR. PI: Rochon, Elizabeth. 102,368 CAD. [Grants].

2005 Dec - 2008 Dec	Principal Investigator. Serotonin PET Imaging in the Neuropsychiatry of Dementia (80%). University of Toronto Dean’s Fund for New Staff. 10,000 CAD. [Grants].

2003 Jun - 2006 Dec	Principal Applicant. Serotonergic Function in Dementia (80%). NIA. National Research Service Award (F32). PI: Chow, Tiffany. 162,000 USD. [Grants].

2002 Feb - 2003 Feb	Principal Applicant. Serotonin and PET in Frontotemporal Dementia. NIA. Alzheimer’s Disease Research Center Pilot Project Grant. PI: Chow, Tiffany. 30,000 USD. [Grants].

NON-PEER-REVIEWED GRANTS
Funded

2009 Jul - 2011 Mar	Principal Investigator. Extension of Lundbeck Investigator-Initiated Trial, Open-Label Pilot Study of the Effects of Acute Memantine Administration on FDG-PET in Frontotemporal Dementia. Lundbeck Canada Inc. 40,500 CAD. [Grants].

2006 Dec - 2011 Jan	PI, major role in designing the study protocol, designated principal author. Open-Label Pilot Study of the Effects of Acute Memantine Administration on FDG-PET in Frontotemporal Dementia. Lundbeck Canada Inc. Lundbeck Investigator-Initiated Trial. PI: Chow, Tiffany. 189,972 CAD. [Grants].

Salary Support and Other Funding
PERSONAL SALARY SUPPORT
2010 Jan - present	Women of Baycrest. Baycrest. 100,000 CAD. Toronto, Ontario, Canada.

TRAINEE SALARY SUPPORT
2008 Jul - 2009 Jul	Moir Family Fund. Trainee Name: Omer Grigg. University of Toronto. 12,445 CAD. Toronto, Ontario, Canada.

D. Publications
1. MOST SIGNIFICANT PUBLICATIONS
1.	Principal Author. T.W. Chow, A. Graff-Guerrero, N.P.G. Verhoeff, M.A. Binns, D.F. Tang-Wai, M. Freedman, M. Masellis, S.E. Black, A.A. Wilson, S. Houle, B.G. Pollock. An open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia. Neuropsychiatric Disease and Treatment. 2011; 7(1):415 - 424. (70% contribution).
2.	Senior Responsible Author. N.A.S. Farb,C.L. Grady, D.F. Tang-Wai, M. Masellis, S.E. Black, M. Freedman, B.G. Pollock, T.W. Chow. Abnormal resting-state network connectivity in frontotemporal dementia. PLOS: Computational Biology. submitted (40% Contribution).
3.	Corresponding Author. H. Uchida, T.W. Chow, D.C. Mamo, S. Kapur, B.H. Mulsant, S. Houle, B.G. Pollock, A. Graff-Guerrero. Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections. 2011; International Journal of Geriatric Psychiatry, doi: 10.1002/gps.2682. [Epub ahead of print] (33% Contribution). Impact Factor 1.981. 

This paper explains why exploration of serotonergic function, although highly implicated in dementing illness, still remains out of our grasp as a biomarker.
4.	Principal Author. T. W. Chow,  F. Gao, K.A. Links, J. E. Ween, D. F. Tang-Wai, J. Ramirez, C.J.M. Scott, M. Freedman, D. T. Stuss, S. E. Black. Visual rating vs. volumetry to detect frontotemporal dementia. Dementia and Geriatric Cognitive Disorders. 2011;31:371-378 (50% Contribution). Impact Factor 2.578. 

This follow-up to our 2008 study showing great overlap in frontotemporal atrophy among controls and patients with frontotemporal dementia illustrates the difficulty of applying regional atrophy criteria to a case-by-base clinical setting.
5.	Principal Author. T.W. Chow, M.A. Binns, R. van Reekum, M. Freedman, J.L. Cummings, I. Lam, S.E. Black, B.L. Miller. Apathy symptom profile and behavioral associations in frontotemporal dementia vs. dementia of Alzheimer type. Archives of Neurology, 2009, 66(7):888-93. (60% contribution). Impact Factor 5.87. 

We demonstrate in this paper that the historical separation of FTD patients into apathetic vs disinhibited classifications may be erroneous. In our study blending neuropsychiatric inventory data from the U of T, UCSF and UCLA, we show that patients with apathy are more likely to have severe agitation and disinhibition than when apathy is absent.
6.	Senior Responsible Author. A. Grinberg, J. Lagunoff, D. Phillips, B. Stern, M. Goodman, T.W. Chow. Multidisciplinary design and implementation of a day program specialized for the frontotemporal dementias. American Journal of Alzheimer’s Disease and Other Disorders 2008 27(6): 499-506. (70% Contribution). Impact Factor 3.14. 

Although not a scientific paper, international interest in how we created day program activities and supervision for early-onset FTD patients continues into 2011. This may be my paper with the largest impact on quality of life for FTD patients and their caregivers.
7.	Principal Author. T.W. Chow, S. Takeshita,  K. Honjo, C.E. Pataky, P.L. St. Jacques, M.L. Kusano, C. B. Caldwell, J. Ramirez, S. Black, N.P.L.G. Verhoeff. Comparison of manual and semi-automated delineation of regions of interest for radioligand PET imaging analysis. British Nuclear Medicine 2007 7: 2 (online publication). (50% Contribution). Impact Factor 1.435. 

This paper justifies the use of semi-automated methods for PET imaging analysis. It was timely in 2007 and allows for imaging researchers to decrease the manhours required for analysis.
2. PEER-REVIEWED PUBLICATIONS
Journal Articles
1.	Co-Principal Author. J.C. Wong, T.W. Chow, L-N. Hazrati. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia can present as frontotemporal dementia syndrome. Dementia and Geriatric Cognitive Disorders. 2011. In Press. Impact Factor 2.58.
2.	Coauthor or Collaborator. K. Rascovsky, J.R. Hodges, D. Knopman, M.F. Mendez, J.H. Kramer, J. Neuhaus, J.C. van Swieten, H. Seelaar, E.G.P. Dopper, C.U. Onyike, A.E. Hillis, K.A. Josephs, B.F. Boeve, A. Kertesz, W.W. Seeley, K.P. Rankin, J.K. Johnson, M. Gorno-Tempini, H. Rosen, C. Latham, A. Lee, C.M. Kipps, P. Lillo, O. Piguet, J.D. Rohrer, M.N. Rossor, J.D. Warren, N.C. Fox, D. Galasko, D.P. Salmon, S. E. Black, M. Mesulam, S. Weintraub, B.C. Dickerson, J. Diehl-Schmid, F. Pasquier, V. Deramecourt, F. Lebert, Y. Pijnenburg, T.W. Chow, F. Manes, J. Grafman, S.F. Cappa, M. Freedman, M. Grossman, and B.L. Miller. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; in press. In Press.
3.	Coauthor or Collaborator. N. Herrmann, S.E. Black, T.W. Chow, J. Cappell, D. F. Tang-Wai, K.L. Lanctot. Serotonergic function and treatment of behavioural and psychological symptoms of frontotemporal dementia. Am J Geriatr Psychiat. In Press.
4.	Principal Author. T.W. Chow. What Are the Initial Presentations of Frontotemporal Dementia? Journal of Molecular Neuroscience. 2011; http://www.springerlink.com/content/02334847p6416m22/  doi:10.1007/s12031-011-9561-z.
5.	Principal Author. T.W. Chow, F.J. Pio, K. Rockwood. An International Needs Assessment of Caregivers for Frontotemporal Dementia Syndromes. Canadian Journal of Neurological Sciences. 2011;. In Press.
6.	Senior Responsible Author. T. W. Chow, K. A. Links,  D.L. Masterman, M.F. Mendez, H.V. Vinters. A case of frontotemporal dementia with severe insular atrophy. Neurocase (50% Contribution). In Press. Impact Factor 6.312.
7.	Senior Responsible Author. K. A. Links, D. Merims, M. A. Binns, M. Freedman, T. W. Chow. Prevalence of primitive reflexes and parkinsonian signs in dementia. Canadian Journal of Neurological Science 2010; 37(5): 601-607 (50% Contribution). Impact Factor 1.041.
8.	Coauthor or Collaborator. R.N. Spreng, H. Rosen, S. Strother, T.W. Chow, J. Diehl-Schmid, M. Freedman, N. Graff-Radford, J. Hodges, A. Lipton, M. Mendez, S. Morelli, S.E. Black, B.L. Miller, B. Levine. Occupation attributes relate to location of atrophy in frontotemporal lobar degeneration. Neuropsychologia 2010 Oct;48(12):3634-41.
9.	Coauthor or Collaborator. R.A. Hurley, L.A. Flashman, T.W. Chow, K.H. Taber. The Brainstem: Anatomy, Assessment, and Clinical Syndromes. Journal of Neuropsychiatry and Clinical Neuroscience 22(1): iv, 1-7. Impact Factor 2.336.
10.	Coauthor or Collaborator. R. Petrican, N. Gopie, L. Leach, T. W. Chow, B. Richards, M. Moscovitch. Recollection and familiarity for public events in neurologically intact older adults and two brain-damaged patients. Neuropsychologia  2010 Mar;48(4):945-60.
11.	Principal Author. T.W. Chow, A. Varpetian, T. Moss, H.V. Vinters, S. Marquez, C. Miller. Alzheimer’s disease neuropathologic changes in semantic dementia. Neurocase 2010;16(1):15-22 (80% contribution). Impact Factor 0.92.
12.	Principal Author. T.W. Chow, D.C. Mamo, H.Uchida, A. Graff-Guerrero, S. Houle, G.S. Smith, B.G. Pollock, B.H. Mulsant. Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults. Biomed Central Medical Imaging,2009, 6(9):12. (50% contribution). Impact Factor 1.7.
13.	Senior Responsible Author. K.A. Links, T.W. Chow, M.A. Binns, M. Freedman, D.T. Stuss, C.J.M. Scott, J. Ramirez, S.E. Black. Apathy is not associated with basal ganglia atrophy in frontotemporal dementia. American Journal of Geriatric Psychiatry,2009, 17(9):819-21. (70% contribution). Impact Factor 4.022.
14.	Principal Author. T.W. Chow, C. Binder, A. Robillard, S. Smyth, S. Cohen. 100 years after Alzheimer: contemporary neurology practice assessment of referrals for dementia. American Journal of Alzheimer Disease and Other Disorders,2009, 23(6): 516-527. (75% Contribution). Impact Factor 3.14.
15.	Principal Author. T.W. Chow, A. Izenberg, M. A. Binns, M. Freedman, D.T. Stuss, J. Ramirez, S. Black. Magnetic resonance imaging in frontotemporal dementia shows subcortical atrophy. Dementia and Geriatric Cognitive Disorders, 2008; 26: 79-88 (75% Contribution). Impact Factor 2.578.
16.	Principal Author. T.W. Chow, M. A. Binns, M. Freedman, D.T. Stuss, J. Ramirez, C.J.M. Scott, S. Black. Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Disease and Associated Disorders 2008, 22(4):327-335. (60% Contribution). Impact Factor 3.22.
17.	Coauthor or Collaborator. D. Krawczyk, R.G. Morrison, I.V. Viskontas, K.J. Holyoak, T.W. Chow, M.F. Mendez, B.L. Miller, B.J. Knowlton. Distraction during relational reasoning: the role of prefrontal cortex in interference control. Neuropsychologia 2008; 46(7): 2020-2032. (10% Contribution). Impact Factor 4.72.
18.	Coauthor or Collaborator. H.H. Feldman, A. Robillard, A. Garcia, T.W. Chow,  M. Borrie, H.M. Schipper, C. Jacova, M. Blair, A. Kertesz. The diagnosis of dementia. CMAJ 2008; 178(7): 825–836 (33% Contribution). Impact Factor 6.9.
19.	Coauthor or Collaborator. K. Rascovsky, J.R. Hodges, C. M. Kipps, J. K. Johnson, W. W. Seeley, M. F. Mendez, D. Knopman, A. Kertesz, M. Mesulam, D. P. Salmon, D.Galasko, T.W. Chow, C. DeCarli, A. Hillis, K. Josephs, J. H. Kramer, S. Weintraub, M. Grossman, M. Gorno-Tempini, B.M. Miller. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Disease and Associated Disorders ;21(4):S14-8 (10% Contribution). Impact Factor 1.99.
20.	Principal Author. T.W. Chow, B.G. Pollock, N.W. Milgram. SSRIs for treatment of cognition in AD and potential disease modification. Neuropsychiatric Disease and Treatment, 2007; 3(5): 627-636. (80% Contribution). Impact Factor 0.46.
21.	Principal Author. T.W. Chow. Structural Neuroimaging in the Diagnosis of Dementia. Alzheimer’s and Dementia 2007; 3(4): 333-335. (100% Contribution). Impact Factor 3.22.
22.	Coauthor or Collaborator. P.S.R. Davidson, D. Anaki, J. Saint-Cyr, T.W. Chow, M. Moscovitch. Exploring the recognition memory deficit in Parkinson’s disease: estimates of recollection versus familiarity. Brain 2006; 129(Pt 7): 1768-79. (15% Contribution). Impact Factor 7.617.
23.	Principal Author. T.W. Chow, A.M. Lipton, L.S. Hynan. MMSE scores decline at a greater rate in frontotemporal degeneration than in AD. Dementia and Geriatric Cognitive Disorders 2006; 22: 194-199. (75% Contribution). Impact Factor 2.511.
24.	Coauthor or Collaborator. A.M. McMurtray, A. Chen, J.S. Shapira, T.W. Chow, F. Mishkin, B.L. Miller, M.F. Mendez. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology 2006; 66(4): 517-522. (10% Contribution). Impact Factor 4.63.
25.	Senior Responsible Author. R.S. Jones, T.W. Chow, M. Gatz. Asian Americans and Alzheimer’s Disease: Assimilation, Culture, and Beliefs. Journal of Aging Studies 2006; 20(1): 11-25. (50% Contribution). Impact Factor 0.966.
26.	Coauthor or Collaborator. T. Haritunians, T. Chow, R.P.J. De Lange, J.T. Nichols, D. Ghavimi, N. Dorrani, D.M. St. Clair, G. Weinmaster, C. Schanen. Functional analysis of a recurrent missense mutation in Notch3 in CADASIL. Journal of Neurology, Neurosurgery & Psychiatry 2005; 76(9): 1242-8. (15% Contribution). Impact Factor 3.63.
27.	Principal Author. T.W. Chow. Treatment Approaches to Symptoms Associated with Frontotemporal Degeneration. Current Psychiatry Reports 2005, 7(5): 376-380. (100% Contribution). Impact Factor 3.78.
28.	Coauthor or Collaborator. J.K. Johnson, J. Diehl, M.F. Mendez, T. W. Chow, J. Neuhaus, C. Pace-Savitsky, J.S. Shapiro, H.J. Rosen, H. Forstl, A. Kurz, and B.L. Miller. Frontotemporal lobar degeneration - Demographic characteristics of 353 patients. Archives of Neurology 2005; 62(6): 925-930. (10% Contribution). Impact Factor 5.204.
29.	Principal Author. T.W. Chow, J. Hodges, K. Dawson, B.L. Miller, V. Smith, M.F. Mendez, A.M. Lipton, National Alzheimer’s Coordinating Center. Referral Patterns for Syndromes Associated with Frontotemporal Lobar Degeneration. Alzheimer’s Disease and Associated Disorders 2005, 19(1): 17-9. (70% Contribution). Impact Factor 1.99.
30.	Coauthor or Collaborator. D.B. Arciniegas, E.C. Lauterbach, K.E. Anderson, T.W. Chow, L.A. Flashman, R.A. Hurley, D.I. Kaufer, T.W. McAllister, A.Reeve, R.B. Schiffer, J.M. Silver. The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting. CNS Spectrums. 2005;10 (5 Suppl): 1-14.
31.	Principal Author. W. Mok, T.W. Chow, L. Zheng, W.J. Mack, C. Miller. Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians. American Journal of Alzheimer’s Disease and Related Disorders, 2004, 19(3): 161-165. (60% Contribution). Impact Factor 3.14.
32.	Coauthor or Collaborator. J.A. Waltz, B.J. Knowlton, K.J. Holyoak, S. McPherson, K.B. Boone, C. Back, E. Reback, S. O’Connor, D. Masterman, T. Chow, J.L. Cummings, B.L. Miller. Relational integration and executive function in Alzheimer’s disease. Neuropsychology, 2004, 18: 296-305. (10% Contribution). Impact Factor 3.123.
33.	Coauthor or Collaborator. R.G. Morrison, D. C. Krawczyk, K. J. Holyoak, J.E. Hummel, T. W. Chow, B.L. Miller, B. J. Knowlton. A neurocomputational model of analogical reasoning and its breakdown in frontotemporal lobar degeneration. Journal of Cognitive Neuroscience, 2004, 16: 260-271. (10% Contribution). Impact Factor 5.197.
34.	Principal Author. T.W. Chow. Frontotemporal dementia: clinical features and management. Seminars in Clinical Neuropsychiatry. 2003; 8(1): 58-70.
35.	Co-Principal Author. E. J. Mills, T.W. Chow. Randomized controlled trials in long-term care residents with dementia: a systematic review. Journal of the American Medical Directors Association, 2003 Nov-Dec, 4(6): 302-7. (50% Contribution). Impact Factor 23.5.
36.	Coauthor or Collaborator. M. J. Sobrido, B. L. Miller, N. Havlioglu, V. Zhukareva, Z. Jiang, Z.S. Nasreddine, V. M.-Y. Lee, J.L. Cummings, T. W. Chow, K. C. Wilhelmsen, J.Y. Wu, D.H. Geschwind. Novel tau polymorphisms, tau haplotypes and splicing in familial and sporadic frontotemporal dementia. Archives of Neurology, 2003, 60: 698-702. (10% Contribution). Impact Factor 5.204.
37.	Principal Author. T.W. Chow, A. Graff-Guerrero, N.P.G. Verhoeff, M.A. Binns, D.F. Tang-Wai, M. Freedman, M. Masellis, S.E. Black, A.A. Wilson, S. Houle, B.G. Pollock. An open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia. Neuropsychiatric Disease and Treatment. 2011; 7(1):415 - 424. (70% contribution).
38.	Corresponding Author. H. Uchida, T.W. Chow, D.C. Mamo, S. Kapur, B.H. Mulsant, S. Houle, B.G. Pollock, A. Graff-Guerrero. Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections. 2011; International Journal of Geriatric Psychiatry, doi: 10.1002/gps.2682. [Epub ahead of print] (33% Contribution). Impact Factor 1.981.
39.	Principal Author. T. W. Chow,  F. Gao, K.A. Links, J. E. Ween, D. F. Tang-Wai, J. Ramirez, C.J.M. Scott, M. Freedman, D. T. Stuss, S. E. Black. Visual rating vs. volumetry to detect frontotemporal dementia. Dementia and Geriatric Cognitive Disorders. 2011;31:371-378 (50% Contribution). Impact Factor 2.578.
40.	Principal Author. T.W. Chow, M.A. Binns, R. van Reekum, M. Freedman, J.L. Cummings, I. Lam, S.E. Black, B.L. Miller. Apathy symptom profile and behavioral associations in frontotemporal dementia vs. dementia of Alzheimer type. Archives of Neurology, 2009, 66(7):888-93. (60% contribution). Impact Factor 5.87.
41.	Senior Responsible Author. A. Grinberg, J. Lagunoff, D. Phillips, B. Stern, M. Goodman, T.W. Chow. Multidisciplinary design and implementation of a day program specialized for the frontotemporal dementias. American Journal of Alzheimer’s Disease and Other Disorders 2008 27(6): 499-506. (70% Contribution). Impact Factor 3.14.
42.	Principal Author. T.W. Chow, S. Takeshita,  K. Honjo, C.E. Pataky, P.L. St. Jacques, M.L. Kusano, C. B. Caldwell, J. Ramirez, S. Black, N.P.L.G. Verhoeff. Comparison of manual and semi-automated delineation of regions of interest for radioligand PET imaging analysis. British Nuclear Medicine 2007 7: 2 (online publication). (50% Contribution). Impact Factor 1.435.
Abstracts
1.	Coauthor or Collaborator. N. Herrmann, S. Black, T.W. Chow, M. Freedman, K. Lanctôt. Prolactin response to citalopram challenge predicts behavioural improvement in frontotemporal dementia. Presented at the 14th International Congress of the International Psychogeriatric Association, Montreal, September 2009. Int Psychogeriatr 2009; 21(2): S102.
2.	Principal Author. T. W. Chow, M. A. Binns, M. Freedman, B.G. Pollock, N.P. Verhoeff, A. Graff-Guerrero. Pre- and post-memantine FDG-PET imaging in frontotemporal dementia. Am J Geriatr Psychiatry 2009;17(3 Supp 1): A73.
3.	Coauthor or Collaborator. R.N. Spreng, H.J. Rosen, S.E. Black, T.W. Chow, J. Diehl-Schmid, M. Freedman, N.R. Graff-Radford, J.R. Hodges, A.M. Lipton, M.F. Mendez, S.A. Morelli, B.L. Miller, B. Levine. Occupation attributes relate to laterality of atrophy in frontotemporal lobar degeneration. Dem Geri Cog Dis 2008; 26(suppl 1): 37.
4.	T.W. Chow, M.A. Binns, R. van Reekum, M. Freedman, J.L. Cummings, I. Lam, S.E. Black, B.L. Miller. Apathy is associated with harmful behaviors in frontotemporal dementia and Alzheimer’s disease. Dem Geri Cog Dis 2008; 26(suppl 1): 71. Impact Factor 2.578.
5.	H. Uchida, T.W. Chow, D.C. Mamo, S. Houle, G. Smith, B.G. Pollock, B.H. Mulsant. Reliability of evaluation of cortical 5HT2 receptors in older adults with [18F]-setoperone PET imaging. Brain and Cognition 2008 [online publication].
6.	T. Chow, P. Rusjan, J. Meyer, N.P. Verhoeff, B.G. Pollock, G. Smith. Frontal-subcortical circuits and a rationale for neuroreceptor quantification in frontotemporal dementia. Neuropsychopharmacology 2006; 31(Supp 1): S48.
7.	T.W. Chow, M. A. Binns, M. Freedman, D.T. Stuss, J. Ramirez, S. Black. The diagnostic utility of regional atrophy in frontotemporal degeneration. Alzheimer’s and Dementia 2006; 2(3 Supp 1): S323.
8.	A. Izenberg, T.W. Chow, M.A. Binns, M. Freedman, D.T. Stuss, J. Ramirez, S.E. Black. Early stages of FTD show subcortical atrophy. Neurology 2006; 66(Suppl2): A193.
9.	M.L. Kusano, C.B. Caldwell, K.L. Lanctot, and T.W. Chow. Evaluation and refinement of an MR-based brain pet partial volume correction method using the Zubal brain phantom. J Nucl Med. 2005; 46(Supplement 2): 452P.
10.	T.W. Chow, N. P.L.G. Verhoeff, S. Takeshita, M. Freedman, S. Black, A. Wilson, D. Hussey, S. Houle, J. Meyer. Reduced serotonin 1a receptor binding potential and abnormal oral behaviors in frontotemporal degeneration. Neurology, 2005, 64 (Supp 1): A228.
11.	T.W. Chow. Evidence-based management of frontotemporal degeneration with serotonergic agents. International Psychogeriatrics, 2005, 17 (Supp 2): 86.
12.	A. Lipton, T.W. Chow, L. Hynan. MMSE scores decline at a greater rate in Frontotemporal lobar degeneration than in Alzheimer’s disease. Neurology, 2003, 60(S1): A375.
13.	D. C. Krawczyk, R.G. Morrison, K. J. Holyoak, T.W. Chow, M. Mendez, B.J. Knowlton. The role of prefrontal cortex in inhibiting competing perceptual and semantic information in relational reasoning. Proceedings of the 10th annual meeting of the Cognitive Neuroscience Society, p. 167. (2003).
3. NON-PEER-REVIEWED PUBLICATIONS
Journal Articles
1.	Principal Author. T.W. Chow. A dementia by any other name. What if it is not Alzheimer’s? Alzheimer’s Care Quarterly. 2005; 6(3): 215-224.
Abstracts
1.	Principal Author. TW Chow. A Brief History of Research in Frontotemporal Dementia (and Celebration of Bruce Miller’s Impact on it). Frontiers in Human Neuroscience 2010.  doi: 10.3389/conf.fnins.2010.14.00032.
2.	T.W. Chow, N. P.L.G. Verhoeff, S. Takeshita, P.L. St. Jacques, M. Freedman, S. Black, A. Wilson, D. Hussey, S. Houle,J. Meyer. Depression in frontotemporal dementia is associated with decreased left temporal lobe 5HT1a receptor density. Annals of Neurology, 2004, 56(S8): S17.
Book Chapters
1.	Principal Author. T.W. Chow. When Is Frontotemporal Atrophy Normal? Chapter in Amyotrophic Lateral Sclerosis and the Frontotemporal Dementias.  M. Strong, ed. 2010. Oxford: Oxford University Press, In Press. In Press.
2.	Co-Principal Author. T.W. Chow and J.L. Cummings. Frontal-subcortical circuits. Chapter in The Human Frontal Lobes: Functions and Disorders, 2nd ed., Miller B.L. and Cummings J.L., eds. 2006. New York: Guilford Press, pp. 25-43.
3.	Principal Author. T.W. Chow. Therapeutic interventions for frontotemporal dementias. In L. Radin, G. Radin, M. Grossman, eds. 2004.  What If It’s Not Alzheimer’s? A Caregiver’s Guide to Frontotemporal Dementia, Prometheus Books, 300 pages.
Commentaries
1.	Principal Author. T. W. Chow. Review: insufficient evidence on Huperzine A for Alzheimer’s. Evidence-Based Mental Health. 11(4): 112. doi: 10.1136/ebmh.11.4.112.
4. SUBMITTED PUBLICATIONS
Journal Articles
1.	Senior Responsible Author. N.A.S. Farb,C.L. Grady, D.F. Tang-Wai, M. Masellis, S.E. Black, M. Freedman, B.G. Pollock, T.W. Chow. Abnormal resting-state network connectivity in frontotemporal dementia. PLOS: Computational Biology. submitted (40% Contribution).
2.	Senior Responsible Author. K. A. Links, S. E. Black, T. W. Chow. A case of apathy due to frontotemporal dementia responsive to memantine. Neurocase (50% Contribution). Impact Factor 6.312.
3.	Coauthor or Collaborator. E. D. Kaye, K. Honjo, A. Petrovic-Poljak, R. van Reekum, D.L. Streiner, A.A. Wilson, S.E. Black, M. Freedman, P. Rusjan, S. Houle, T. W. Chow, N.P.L.G. Verhoeff. An [11C]SB-13 PET study correlating neuropsychiatric symptoms in Alzheimer’s disease with regional beta-amyloid burden. Journal of Neuropsychiatry and Clinical Neurosciences.
E. Presentations and Special Lectures
1. International
Abstracts and Other Papers
2011 Apr 12	Invited Speaker. [S04.002] The Impact of the Right Insula on Behavior and Cognition in Frontotemporal Dementia. American Academy of Neurology. Honolulu, Hawaii, United States. Presenter(s): N. Farb, T.W. Chow, D. Tang-Wai, M. Masellis. Neurology 2011;76(Supp 4): A177. (Patients/Public Presentation by Trainee).
2011 Apr 12	Collaborator. [S14.001] Sensitivity of Diagnostic Criteria in Autopsy-Confirmed Patients with Behavioral Variant Frontotemporal Dementia (bvFTD): First Report of the International bvFTD Criteria Consortium. American Academy of Neurology. Honolulu, Hawaii, United States. Presenter(s): K. Rascovsky, J. Hodges, D. Knopman...T.W. Chow, F. Manes, J. Grafman, S. Cappa, M. Freedman, J. Warren, N. Fox, M. Grossman, B. Miller. Neurology 2011;76(Supp 4): A262-263. (Patients/Public Presentation by Trainee).
2008 Mar	Reliability of evaluation of cortical 5HT2 receptors in older adults with [18F]-setoperone PET imaging. Rotman Research Institute Annual Conference Neuroimaging Dementia. Toronto. H. Uchida, T.W. Chow, D.C. Mamo, S. Houle, G. Smith, B.G. Pollock, B.H. Mulsant. Poster presentation.
2006 Sep	Alexithymia in dementia. UCSF International Conference on Frontotemporal Dementia. San Francisco. C.E. Pataky, P. St. Jacques, P. Davidson, C. Grady, T.W. Chow. Poster presentation.
2006 Sep	Iatrogenic apathy in frontotemporal dementia. UCSF International Conference on Frontotemporal Dementia. San Francisco. T.W. Chow, M.A. Binns, C. E. Pataky, D. Huang, T. Yeo, J.L. Cummings, I. Lam, S.E. Black, S. Kelly, B.L. Miller, M. Freedman. Poster presentation.
2006 Aug	Comparative utility of linear, area and volumetric measures in detecting brain changes in FTD in correlation with cognitive performance. UCSF International Conference on Frontotemporal Dementia. San Francisco. F.Q. Gao, N. Deshpande, J. Ramierez, S. Van Gaal, T. Chow, M. Freedman, P. Behl, S.E. Black. Poster presentation.
2006 Jul 16	Left Orbitofrontal Atrophy Correlates with Disinhibition and Apathy in Frontotemporal Degeneration. International Congress of Alzheimer’s Disease. Madrid, Madrid, Spain.
2005 Feb	Neuropsychiatry in frontotemporal degeneration correlates with right dorsolateral prefrontal and left temporal atrophy. 16th Annual Meeting of the American Neuropsychiatric Association. Florida. T.W. Chow, M.A. Binns, J. Ramirez, S.E. Black. Poster presentation.
2005	Recognition memory for emotional stimuli in frontotemporal dementia. Cognitive Neurosciences. St. Jacques, P.L., Chow, T.W., Grady, C.L., Davidson, P.S.R., Pataky, C.E., Springer, M. Poster presentation. (Trainee Presentation).
2004 Oct	Spousal caregiving for frontotemporal dementia. Symposium for Frontotemporal Dementia, Kunin-Lunenfeld Applied Research Unit Conference. Toronto, Ontario. L. McCleary, E. Marziali, T. Chow. Poster presentation.
2004 Jul	Supporting Caregivers of Patients with Frontotemporal Dementia. Symposium for Frontotemporal Dementia. Philadelphia, Pennsylvania. L. McCleary, E. Marziali, T. Chow. Poster presentation.
2004 Jul	Volumetric correlation of basal ganglia and physical disability in frontotemporal lobar degeneration. Symposium for Frontotemporal Dementia. Philadelphia, Pennsylvania. V.S. Thomas, P.L. St. Jacques, T.W. Chow. Poster presentation.
2004 Jul	Reduced serotonin 1a receptors in depressed frontotemporal lobar degeneration subjects. Symposium for Frontotemporal Dementia. Philadelphia, Pennsylvania. T.W. Chow, N.P.L.G. Verhoeff, S. Takeshita, P.L. St. Jacques, M. Freedman, S. Black, A. Wilson, D. Hussey, S. Houle, J. Meyer.
2004	Cognitive decline, Gerstmann syndrome, and apraxia in a case of Corticobasal Ganglionic Degeneration (CBGD). 28th International Congress of Psychology. Beijing. A.L. Siegenthaler, K.A. Stokes, N.W. Park & T.W. Chow.
Invited Lectures and Presentations
2011 Jun 15	Invited Lecturer. Implication of the Salience Network in Frontotemporal Dementia. Canadian Neurological Sciences Federation meeting. Toronto, Ontario, Canada. Presenter(s): Annual Dementia Teaching Course:An Update on Frontotemporal Dementia. (Continuing Education).
2011 Apr 10	Invited Lecturer. Moderate to Advanced Stages of Dementia: Palliative Care Questions and Some Answers. American Academy of Neurology Annual Meeting. Toronto, Ontario, Canada. Presenter(s): Course 2ES.003: Advanced Palliative Care and Symptom management of ALS, Alzheimer’s Disease, Parkinson’s Disease, and Brain Tumors. (Continuing Education).
2010 Oct 6	Invited Lecturer. What are the different initial presentations of frontotemporal dementia? Indiana Alzheimer Disease Center, Indiana University School of Medicine. Indianapolis, Iowa, United States. Dement Geriatr Cogn Disord. 2010;30(S1):11. (Presentation to Patients/Public).
2010 May 16	Invited Speaker. What to Pack for Your Aging Journey. International Association for Jewish Homes and Services for the Aging Symposium. Toronto, Ontario, Canada. (Continuing Education).
2010 Apr 11	Invited Lecturer. Has Study of Patients with Dementia Shed Any Light on Brain-Behavior Relationships? American Academy of Neurology Annual Meeting. Toronto, Ontario, Canada. Presenter(s): Structure Function Correlations in Behavioral Neurology Course. (Continuing Education).
2010 Mar 25	Invited Lecturer. A Brief History of Research in Frontotemporal Dementia --and Celebration of Bruce Miller’s Role in It. The Frontal Lobes. 20th Anniversary of the Rotman Research Institute. Toronto, Ontario, Canada. (Continuing Education).
2009 Nov 11	Invited Speaker. What’s on the Differential Diagnosis List for Frontotemporal Dementia? City-wide Behavioural Neurology International Video-teleconference Rounds. Toronto, Ontario, Canada. (Continuing Education).
2009 Jun	Invited Speaker. When Is Frontotemporal Atrophy Normal? Research Workshop on Frontotemporal Dementia in ALS. London, Ontario, Canada. Presenter(s): T. Chow. (Continuing Education).
2009 Feb	Invited Speaker. How Does Your Brainstem Look from the Outside? American Neuropsychiatric Association. San Antonio, Texas, United States. Presenter(s): T. Chow. Neuropsychiatry 101 workshop, American Neuropsychiatric Association Annual Meeting. (Continuing Education).
2008 Mar 26	PET Imaging in Dementia. Rotman Research Institute Conference. Toronto, Ontario, Canada. (Continuing Education).
2007 Jun 10	Early Detection of the Frontotemporal Dementias. 2nd International Research Workshop on Frontotemporal Dementia in ALS. London, Ontario, Canada.
2007 May 5	Focal Cortical Syndromes. Non-AD Dementia course, American Academy of  Neurology. Boston, Massachusetts, United States. (Continuing Education).
2007 May 3	Apathy and other behaviors in frontotemporal dementia. Vertical integration session on frontotemporal dementia, Annual meeting of the American Academy of Neurology. Boston, Massachusetts, United States. (Continuing Education).
2007 Jan 31	Invited Speaker. How does Alzheimer’s research influence the other dementias? Artiss Powell Memorial Lecture, UMDNJ-Robert Wood Johnson Medical School. Piscataway, New Jersey, United States.
2006 Dec 6	Presenter and Panel Chair. Treatment of Frontotemporal Dementia: Identifying Pathophysiologic Targets. Annual Meeting of the American College of Neuropsychopharmacology. Hollywood, Florida. (Continuing Education).
2006 Oct 20	Apathy, depression, incipient dementia? A difficult differential diagnosis. CAMH-KLARU Conference. Toronto, Ontario, Canada. Presenter(s): co-presented with David Mamo. Workshop. (Continuing Education).
2006 Sep 6	Diagnosis of Frontotemporal Dementia. UCSF International Conference on Frontotemporal Dementia. San Francisco, California, United States. (Continuing Education).
2005 Sep 23	Evidence for a Serotonergic Deficit in Frontotemporal Degeneration. International Psychiatric Association Congress. Stockholm, Södermanland, Sweden. (Continuing Education).
2004 Jul 17	Invited Lecturer. A Dementia by Any Other Name. Alzheimer’s Association 12th National Alzheimer’s Disease Education Conference. Philadelphia, Pennsylvania, United States. (Continuing Education).
2003 Nov 15	Invited Lecturer. Evaluating Drug Studies: When Should a Study Cause Me to Change My Practice? University of Arkansas Alzheimer’s Disease Research Center Dementia Update Conference. Little Rock, Arkansas, United States. (Continuing Education).
2003 Mar 15	Successful Coalition Building between Grassroots Organizations and a Mainstream/Corporate Organization. American Society on Aging/National Coalition on Aging Meeting. Chicago, Illinois. Workshop. (Continuing Education).
2003 Mar 15	Dementia among American Ethnic Groups. American Society on Aging/National Coalition on Aging Meeting. Chicago, Illinois, United States. Workshop. (Continuing Education).
Media Appearances
2009 Oct	Presenter. Web presention on “A Million Tweets to Remember” -  www.1mtweets.com (in videos section). www.1mtweets.com. Presenter(s): T. Chow. (Presentation to Patients/Public).
Other Presentations
2011 Mar 25	Session Co-Chair. Frontotemporal Dementia: The Next Therapeutic Frontier. Lou Ruvo Brain Institute. Las Vegas, Nevada, United States. (Continuing Education).
2. National
Abstracts and Other Papers
2009 Oct 2	Presenter. Pre- and Post-Memantine FDG-PET Imaging in Frontotemporal Dementia. 5th Canadian Conference on Dementia. Toronto, Ontario, Canada. Presenter(s): Tiffany W. Chow, Malcolm A. Binns, Morris  Freedman, Bruce  Pollock, Nicholas P. Verhoeff, Ariel  Graff-Guerrero. (Continuing Education).
2009 Oct	Senior, Responsible Author. Prevalence of Primitive Reflexes and Parkinsonism Among Patients with Dementia. Canadian Conference on Dementia. Toronto, Ontario, Canada. Presenter(s): K. Links, D. Merims, M. Binns, M. Freedman, T.W. Chow. Poster presentation for Canadian Conference on Dementia. October, 2009. Toronto, Ontario. (Trainee Presentation).
2003 Oct	Caregiver Reliability in Reporting Symptoms of Dementia among Japanese-Americans in Hawaii. 2nd Canadian Colloquium on Dementia. Montreal. T.W. Chow, W. Mok, C. Vigen, K. Masaki.
Invited Lectures and Presentations
2010 Sep 22	Invited Lecturer. From Prevention to Palliation. Canadian Association of Geriatric Psychiatry, in collaboration with the University of Toronto Division of Geriatric Psychiatry. Toronto, Ontario, Canada. Presenter(s): The Palliative Aspects of Dementia Management (panel workshop). (Continuing Education).
2009 Oct 2	Invited Lecturer. Clinical Impact of Latest Genetics and Neuropath News in FTD. 5th Canadian Conference on Dementia. Toronto, Ontario, Canada. (Continuing Education).
2009 Apr	Invited Speaker. Apathy in Dementia is a Significant Behavioural Challenge. Canadian Geriatric Scoeity. Toronto, Ontario, Canada. Presenter(s): Chow, T. Annual Meeting of Canadian Geriatrics Society,  Toronto, Ontario. (Continuing Education).
2008 Jun 17	Frontotemporal Dementia: Translating Research into Clinical Practice. Dementia Course, Congress of the Canadian Neurological Sciences Federation. Victoria, British Columbia, Canada. (Continuing Education).
2007 Oct 18	Gaze Palsy, Alien Limb, and Chorea: Movement Disorders in Dementia. Canadian Consortium on Dementia. Vancouver, British Columbia, Canada. (Continuing Education).
2007 Oct 18	Speaking of Which: How to Distinguish between Primary Progressive Aphasias in the Clinic. Canadian Consortium on Dementia. Vancouver, Canada. (Continuing Education).
2007 Oct 18	Managing the Frontotemporal Dementias. Canadian Consortium on Dementia. Vancouver, British Columbia, Canada. (Continuing Education).
2006 Dec 6	Speaker and Co-Chair. Frontal-subcortical circuits and a rationale for neuroreceptor quanitification in frontotemporal dementia. Symposium “Treatment of Frontotemporal Dementia: Identifying Pathophysiologic Targets,” Annual Meeting of the American College of Neuropsychopharmacology. Hollywood, Florida, United States. (Continuing Education).
Media Appearances
2009 Jan	Alzheimer Society of Canada Research Ambassador. The Rising Tide of Alzheimers. Canadian Broadcasting Company (CBC). Toronto, Ontario, Canada. Presenter(s): T.Chow. (Presentation to Patients/Public).
2008 May	Invited Speaker. CBC Sunday: Dancing with Parkinson’s. Interview with Andy Barrie and Sarah Robichaud. Canadian Broadcasting Company (CBC). Toronto, Ontario, Canada. Presenter(s): T. Chow.
2008 Apr 21	Rethinking Alzheimer’s. The Agenda with Steve Paikin, TVO. Toronto.
2003 Oct 10	Early Onset Dementias. ‘Health on the Line’ with Avery Haines. Aired on Discovery Canada Health Channel and Toronto One.
3. Provincial / Regional
Invited Lectures and Presentations
2010 Nov 3	Invited Speaker. Can Memantine Bring Salience to the Salience Network? Robarts Research Institute, University of Western Ontario. London, Ontario, Canada. J. Allyn Taylor Symposium. (Continuing Education).
2010 Jun 10	Invited Speaker. What is Frontotemporal Dementia and How Can We Manage It? Alzheimer Society of Sarnia Annual General Meeting. Sarnia, Ontario, Canada. (Presentation to Patients/Public).
2010 Apr 24	Invited Lecturer. Dementia: From Beginning to End. U of T Division of Neurology. Toronto, Ontario, Canada. Presenter(s): Neurology Update 2010. (Continuing Education).
2010 Mar 10	Invited Speaker. Clinical Neuroscience Rounds for the Divisions of Neurology and Neurosurgery: From Breakthroughs in Frontotemporal Dementia to Bedside. Dalhousie University. Halifax, Nova Scotia, Canada. (Continuing Education).
2010 Mar 9	Invited Speaker. Concepts in Caring for Frontotemporal Dementia. Dalhousie University. Halifax, Nova Scotia, Canada. (Presentation to Patients/Public).
2009 Nov 20	Invited Speaker. Is It or Ain’t It FTD? BC Mental Health. Vancouver, British Columbia, Canada. Annual Geriatric Psychiatry Conference. (Continuing Education).
2009 Nov 20	Invited Speaker. Managing the Caregiver and the Patient with Frontotemporal Dementia. BC Mental Health. Vancouver, British Columbia, Canada. Annual Geriatric Psychiatry Conference. (Continuing Education).
2009 Aug	Invited Speaker. The Road to Fearless Caregiving. Northwestern University FTD/PPA Caregiver and Professional Education Conference. Chicago, Illinois, United States. Keynote Speaker. (Presentation to Patients/Public).
2008 Oct 21	Invited Speaker. How Can We Best Support FTD Caregivers? Alzheimer Society of Hamilton and Halton, Caregiver Workshop entitled, “Frontotemporal Dementias: Understanding the Behaviours & Adding to Your Toolkit”. Hamilton, Ontario, Canada. (Presentation to Patients/Public).
2007 Feb 23	Invited Speaker. From Clinic to Genetics Lab and back Again: the Impact of Genetic Breakthroughs. Many Faces of Dementia Conference for University of Southern California and the Los Angeles Alzheimer’s Association. Los Angeles, California, United States. (Continuing Education).
2005 Nov 8	What to Do about Early Onset Dementias. 2nd Annual Dementia Care Providers Network, Sunnybrook and Women’s College Health Sciences Centre. Toronto, Ontario, Canada. (Continuing Education).
2004 Nov 23	Invited Lecturer. Update on Frontotemporal Dementia. Castle Medical Center Medicine Grand Rounds. Kaneohe, Hawaii, United States. (Continuing Education).
2004 Oct 30	Invited Speaker. Update on Frontotemporal Dementia. Annual Meeting of the Minnesota Psychiatric Society. Minneapolis, Minnesota, United States. (Continuing Education).
2004 Apr 1	Ethnic Diversity in Dementia. Annual Conference of the Connecticut Chapter of the Alzheimer’s Association. Connecticut, United States. (Presentation to Patients/Public).
2003 Jun 6	Asian and Pacific Islander Communities’ Response to Guidelines for Alzheimer’s Disease Care. UCSF Memory and Aging Center Team Conference. San Francisco, California, United States. (Continuing Education).
2003 Apr 8	Invited Lecturer. Asian and Pacific Islander Communities’ Response to Guidelines for AD Care. Castle Medical Center Medicine Grand Rounds. Kaneohe, Hawaii, United States. (Continuing Education).
2003 Feb 28	The Big Picture: When & Why to Order Neuroimaging. USC and Alzheimer’s Association of LA, Riverside and San Bernadino Counties Faces of Dementia Conference. (Continuing Education).
2003 Feb 28	The Asian and Pacific Islander Communities’ Response to Guidelines for AD Care. USC and Alzheimer’s Association of LA, Riverside and San Bernadino Counties Faces of Dementia Conference. Los Angeles, California, United States. (Continuing Education).
Media Appearances
2008 Mar 27	Neuroimaging Advances and New Ethical Dilemmas in Alzheimer’s Disease Detection. The Rutherford Show, CHQR AM 770 “Alberta’s #1 talk show”. Calgary.
4. Local
Abstracts and Other Papers
2009 Jun	Senior, Responsible Author. Prevalence of Primitive Reflexes and Parkinsonism Among Patients with Dementia. Harvey Stancer Research Day. Toronto, Ontario, Canada. Presenter(s): K. Links, D. Merims, M. Binns, M. Freedman, T.W. Chow. Poster presentation for University of Toronto Harvey Stancer Day. June, 2009. (Trainee Presentation).
Invited Lectures and Presentations
2011 Mar 10	Invited Speaker. Speaker’s Panel on Bill 52. Donna Cansfield, Ontario MPP. Etobicoke, Ontario, Canada. (Presentation to Patients/Public).
2011 Feb 28	Invited Speaker. Oh, the Things You’ll See with FTD. Rotman Research Institute (weekly rounds). Toronto, Ontario, Canada.
2011 Jan 13	Invited Speaker. What Can We Learn about the Lifespan from Studying Dementia? Institute for Life Course and Aging. Toronto, Ontario, Canada. (Presentation to Patients/Public).
2010 Dec 16	Invited Speaker. What is Frontotemporal Dementia and How Can We Manage It? McGill University Psychiatry and Neurology Rounds. Montreal, Quebec, Canada. (Continuing Education).
2010 Dec 1	Invited Speaker. Clinicopathological Case: Rapidly Progressive Frontotemporal Dementia That on Autopsy, Wasn’t. City-wide Behavioural Neurology International Video-teleconference Rounds. Toronto, Ontario, Canada. Presenter(s): T.W. Chow and L. Hazrati. (Continuing Education).
2010 Aug 9	Invited Speaker. Meet the Scientist. Rotman Research Institute/KLARU Summer Rounds. Toronto, Ontario, Canada. (Trainee Presentation).
2010 Jan 11	Invited Speaker. What’s on the Differential Diagnosis List for Frontotemporal Dementia? Rotman Research Institute (weekly rounds). Toronto, Ontario, Canada.
2008 May 9	Invited Speaker. Managing the Frontotemporal Dementias. McMaster University Geriatric Medicine Grand Rounds. Hamilton, Ontario, Canada. (Continuing Education).
2007 Sep 13	Studying Patients with Dementia using PET Imaging. Centre for Addiction and Mental Health PET Research Seminar. Toronto, Ontario, Canada. (Continuing Education).
2006 May 12	Invited Lecturer. The Neurology of Frontotemporal Degeneration. Dept. of Communication Disorders Conference, Baycrest. Toronto, Ontario, Canada. (Continuing Education).
2006 Jan 13	Early Onset Dementias. Alzheimer’s Society of Toronto. Toronto, Ontario, Canada. (Presentation to Patients/Public).
2005 Jul 26	Evidence Based management of Frontotemporal Dementias: Is There Any? Geriatric Research Education and Clinical Center Noon Educational Series. Minneapolis, Minnesota, United States. (Continuing Education).
2004 Jun 10	What’s New in Dementia Medication and Research? A Look at Frontotemporal Dementia. Toronto Alzheimer’s Society. Toronto, Ontario, Canada. Lecture. (Presentation to Patients/Public).
2004 Apr 16	New Uses for Cholinesterase Inhibitors. Clinical and Ethical Issues in Geriatric Care, Baycrest. Toronto, Ontario, Canada. Lecture. (Continuing Education).
Media Appearances
2010 Feb 10	Discussant. Women and Alzheimer’s Disease: in the Past and for the Future. Baycrest Speakers Series. Toronto, Ontario, Canada. Presenter(s): Libby Znaimer of CTV, T. Chow, MD. (Presentation to Patients/Public).
F. Teaching and Design
Please see the Teaching and Educational Report for details.
G. Research Supervision
1. Graduate Education
2011 Jan - present	Thesis Committee Member, Adriana Shnall, Student's Current Position: MSW, Student's Current Institution: University of Toronto. PhD, Special Needs of Spousal Caregivers to Early-Onset Dementia. Completed 2013.
2010 Sep - present	Primary Supervisor, Norman Farb. Postdoctoral Fellow, An Innovative Approach to Dementia: How Dementia Changes Sense of Self. Completed 2012.
2008 Sep - present	Secondary Supervisor, Christina Pataky. MSc. Completed 2012.
2. Undergraduate MD
2011 May - 2011 Aug	Primary Supervisor, Jonathan Fridhandler, Student's Current Position: Summer Student, Student's Current Institution: University of Toronto. Year 2, Behavioural Course of Dementia: a Longitudinal Survey. Awards: 2011 American Academy of Neurology Medical Student Summer Research Scholarship, $3000.
2005 Apr - 2006 Aug	Primary Supervisor, Aaron Izenberg, Student's Current Position: BScH, Summer Student, completing Queen’s University Medical School Year 2 Research Enquiry Rotation. Years 2-3 of medical school, Neuropsychiatric Inventory as a Test for a New Model of Apathy, Dental Issues for Patients with Dementia, Atrophy in Basal Ganglia in Frontotemporal Dementia. Awards: Selected for platform presentation at annual American Academy of Neurology meeting. Completed 2006.
2004	Co-Supervisor, Hayley Eisenberg, Student's Current Position: BScH, Summer Student. Year 3, Utility of Neuropsychological Evaluations in Diagnosing and Managing Memory Disorders Clinic Patients. Collaborators: Morris Freedman.
3. Postgraduate MD
2007 Jan - 2007 Dec	Co-Supervisor, Kie Honjo, Student's Current Position: MD, PhD. Clinical Fellow, Test-Retest Reliability in Amyloid PET Imaging. Completed 2007.
2002 - 2004	Primary Supervisor, Winnie Mok, Student's Current Position: MD, Geriatric Medicine, International Visiting Scholar to USC, Student's Current Institution: Hong Kong University. Neurobehaviour Fellow, Clinical Audit through the USC Alzheimer’s Disease Research Center Autopsy Database, Japanese-American Caregiver Recognition of Dementia Symptoms.